Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02910323 · ClinicalTrials.gov registry record

The Will Erwin Headache Research Center - Cluster Headache Study

A clinical trial of Trigeminal Neuralgia and Cluster Headache, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
1,500
Enrollment target
1
Study location

NCT02910323 is a study of Trigeminal Neuralgia and Cluster Headache that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,500 participants, below the 5,603-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02910323, a study of Trigeminal Neuralgia and Cluster Headache, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2016-07-12
Est. Completion 2035-12

What the Registry Record Tells You About NCT02910323

The ClinicalTrials.gov registry entry for NCT02910323 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,603-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (73% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Trigeminal Neuralgia appearing as the primary indexed condition, and to 0 interventions.

NCT02910323 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02910323 about?

NCT02910323 is a clinical study titled "The Will Erwin Headache Research Center - Cluster Headache Study". The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.

What is the current status of trial NCT02910323?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2016-07-12. Estimated completion is 2035-12.

What conditions does trial NCT02910323 study?

This clinical trial studies the following conditions: Trigeminal Neuralgia, Cluster Headache, Paroxysmal Hemicrania, Cluster Headaches and Other Trigeminal Autonomic Cephalgias, SUNCT.

Who is sponsoring clinical trial NCT02910323?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02910323 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trigeminal Neuralgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.